trending Market Intelligence /marketintelligence/en/news-insights/trending/6ib-u8zv2uvmjgn3qomklg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

ContraFect prices $10M common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


ContraFect prices $10M common stock offering

ContraFect Corp. priced its offering of 5 million common shares at a $2 per share to raise $10 million in gross proceeds.

The Yonkers, N.Y.-based developer of drugs also granted the underwriters an option to buy up to an additional 750,000 shares.

The offering is expected to close July 31.

Piper Jaffray & Co. and William Blair & Co. LLC are acting as joint book-running managers, and Chardan is acting as the lead manager for the offering.